Summary & Overview
CPT 50957: Percutaneous Endoscopic Examination and Treatment of Kidney/Ureter
CPT code 50957 identifies a percutaneous endoscopic procedure to examine the kidney, renal pelvis, and ureter via an established skin-to-ureter tract, often performed to investigate or treat malignancy. The code captures both diagnostic maneuvers — including biopsy — and therapeutic interventions such as fulguration or incision to ablate tissue. Nationally, this code matters because it represents a complex, procedure-oriented service that can involve multidisciplinary teams, specialized equipment, and significant facility resources.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical indications and typical sites of service, payer coverage patterns and benchmarks where available, common billing and coding considerations, and policy or reimbursement updates relevant to percutaneous endoscopic renal procedures. The summary highlights practice settings, typical resource utilization, and operational implications for ambulatory surgical centers and hospital operating rooms. Data not available in the input is noted where applicable to ensure transparency about missing payer-specific rates, ICD-10 pairings, and taxonomy details.
Billing Code Overview
CPT code 50957 describes an endoscopic examination of the kidney, renal pelvis, and ureter performed through an existing percutaneous tract between the skin and ureter. The procedure may include lesion or tissue biopsy and may use visualization techniques such as fulguration (high‑frequency heat) or incision to destroy tissue. The primary clinical intent for CPT code 50957 is investigation and treatment of suspected or confirmed malignancy within the upper urinary tract.
-
Service type: Endoscopic percutaneous renal/ureteroscopic diagnostic and therapeutic procedure
-
Typical site of service: Ambulatory surgical center or hospital operating room
Clinical & Coding Specifications
Clinical Context
A 64-year-old patient with a history of painless gross hematuria and an incidental renal mass on CT is scheduled for percutaneous nephroscopy through an established nephrostomy tract to evaluate and treat suspected upper tract urothelial carcinoma. The clinical workflow begins with pre-procedure imaging review and pre-op assessment in the urology clinic, including labs, anticoagulation reconciliation, and consent focused on diagnostic endoscopy, targeted biopsy, and possible fulguration or endoscopic tumor ablation. In the procedure suite (typically an operating room or interventional radiology suite), the patient is positioned prone or supine depending on tract orientation. The surgeon advances a flexible or rigid ureteroscope through the existing percutaneous tract into the renal pelvis and ureter to visualize lesions, obtain cold or forceps biopsies, perform fulguration or laser ablation of tumor tissue, and obtain hemostasis. Specimens are submitted to pathology; procedural documentation includes laterality, type of endoscope, biopsy technique, ablation modality, any complications, estimated blood loss, and disposition. Typical sites of service are the hospital operating room or an outpatient ambulatory surgery center for patients with established percutaneous access. The primary clinical intent is investigative tissue diagnosis and endoscopic treatment of suspected or confirmed malignancy, with immediate intraoperative decisions guided by endoscopic findings and frozen section when applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component |